About Senses Pharmaceuticals Private Limited
Data last updated:
Senses Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Til Healthcare Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 November 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2008PTC048422. Its GSTIN is 29AAMCS5853N1ZE (Karnataka). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹5.05 Cr and a paid-up capital of ₹11.12 Lakh. It was formerly known as Senses Pharmaceuticals Limited. It is led by directors including Velayudham Suresh and Rangarajan Vijayaragavan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.08 Cr. For the same year it recorded a net profit of ₹51.15 Lakh (net margin 2%) and EBITDA of ₹2.01 Cr (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 11% over five years.
The company has about 154 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹8.5 Cr and satisfied charges of ₹2.25 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sensespharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressNo.124 5th Main Road Yeshwanthpur, Suburb 2nd Stage, Bangalore, Karnataka, India – 560022
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Senses Pharmaceuticals Private Limited
The main business activities of Senses Pharmaceuticals are trade and manufacturing. In detail, this covers wholesale trading and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Senses Pharmaceuticals Private Limited FY 2025 filings available
Senses Pharmaceuticals Private Limited reported revenue of ₹26.08 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR) of Senses Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Senses Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.01 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹51.15 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Senses Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Senses Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Senses Pharmaceuticals Private Limited
Senses Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indi Pharma Private Limited | ₹26.28 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Goa, India |
| CGG Infra India Private Limited | ₹26.23 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Chennai, Tamil Nadu, India |
| Kemppi India Private Limited | ₹26.18 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | Khed, Maharashtra, India |
| RRB Chemicals Private Limited. | ₹26.18 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | New Delhi, Delhi, India |
| GNH India Pharmaceuticals Limited | ₹26.12 Cr (FY 2025) | •••• | •••• | -36.0% | •••• | Mumbai, Maharashtra, India |
| Senses Pharmaceuticals Private Limited this company | ₹26.08 Cr (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Mits Healthcare Private Limited | ₹26.04 Cr (FY 2024) | •••• | •••• | 19.0% | •••• | Muzaffarnagar, Uttar Pradesh, India |
| Surge Pharmaceuticals Private Limited | ₹25.94 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Vadodara, Gujarat, India |
| Gennichem Healthcare Private Limited | ₹25.92 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Thane, Maharashtra, India |
| Medigraph Pharmaceuticals Private Limited | ₹25.9 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
| Asle Pharmaceuticals Private Limited | ₹25.9 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Senses Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Senses Pharmaceuticals Private Limited
Senses Pharmaceuticals Private Limited is audited by M.K.DANDEKER & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M.K.DANDEKER & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Senses Pharmaceuticals Private Limited
Senses Pharmaceuticals has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Velayudham Suresh | Director | 04 Apr 2018 | 8 Years 6 Months | Current |
| Rangarajan Vijayaragavan Also directs: Injectalis Lifesciences Private Limited, Til Healthcare Private Limited, Transe Vision Care Private Limited and 3 more | Director | 10 Jun 2022 | 4 Years 4 Months | Current |
| Sundaresan Rajagopalan | Director | 04 Apr 2018 | 8 Years 6 Months | Current |
| Kapil Jhaver | Director | 09 Jun 2020 | 6 Years 4 Months | Current |
Ownership and Shareholding of Senses Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Senses Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2015 | Hdfc Bank Limited | ₹8.5 Cr | Open |
| 12 Apr 2016 | Others | ₹25 Lakh | Satisfied |
| 10 Sep 2009 | State Bank of India | ₹2 Cr | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Senses Pharmaceuticals Private Limited
Senses Pharmaceuticals Private Limited has 3 court cases on record: 2 filed by Senses Pharmaceuticals, 1 filed against it. All cases are disposed. Status as checked between 01 Oct 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (Com.EX.) | Filed by the company against Sen Pharma | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by an individual | Disposed |
| District court, BENGALURU, Karnataka | Court case (Com.O.S.) | Filed by the company against Sen Pharma | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Senses Pharmaceuticals Private Limited
Senses Pharmaceuticals Private Limited has 10 MSME Form 1 returns on record between 2019 and 2024, listing 252 overdue payments to 50 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 50)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ramya Reprographic Private Limited | •••• | •••• | •••• |
| Tanmed Pharma India Private Limited | •••• | •••• | •••• |
| Genomic Scientific | •••• | •••• | •••• |
| Asoj Soft Caps Pvt Ltd | •••• | •••• | •••• |
| Advanced Microdevices Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 10 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Senses Pharmaceuticals Private Limited
Senses Pharmaceuticals Private Limited has a workforce of 154 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Senses Pharmaceuticals Private Limited
Senses Pharmaceuticals has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
CIN History of Senses Pharmaceuticals Private Limited
Senses Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232KA2008PLC048422. The current CIN is U24232KA2008PTC048422, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232KA2008PTC048422 | Current |
| U24232KA2008PLC048422 | Previous |
Recent Activity on Senses Pharmaceuticals Private Limited
Senses Pharmaceuticals Private Limited has 15 board changes on record since 2010: 4 appointments and 11 cessations. The latest: Kapil Jhaver ceased to be Nominee Director on 07 Jun 2023.
13 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Senses Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Senses Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Senses Pharmaceuticals Private Limited
Senses Pharmaceuticals has 4 GST registrations: 4 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAMCS5853N1ZE | Karnataka | Active | 01 Jul 2017 |
| 24AAMCS5853N1ZO | Gujarat | Active | 29 Feb 2024 |
| 21AAMCS5853N1ZU | Odisha | Active | 25 Apr 2024 |
| 07AAMCS5853N1ZK | Delhi | Active | 01 Jul 2024 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Senses Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Senses Pharmaceuticals Private Limited
Senses Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 November 2008 (18+ years old) and is registered under CIN U24232KA2008PTC048422.
Senses Pharmaceuticals reported revenue of ₹26.08 Cr for FY 2025.
Senses Pharmaceuticals has 4 current directors:
- Velayudham Suresh - Director
- Rangarajan Vijayaragavan - Director
- Sundaresan Rajagopalan - Director
- Kapil Jhaver - Director
Senses Pharmaceuticals reported a net profit of ₹51.15 Lakh (net margin 2%) and EBITDA of ₹2.01 Cr (EBITDA margin 7.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Senses Pharmaceuticals is 25% over three years and 11% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Senses Pharmaceuticals is 29AAMCS5853N1ZE, registered in Karnataka. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 24AAMCS5853N1ZO (Gujarat), 21AAMCS5853N1ZU (Odisha), 07AAMCS5853N1ZK (Delhi).
The CIN (Corporate Identification Number) of Senses Pharmaceuticals is U24232KA2008PTC048422. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Senses Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it.
Senses Pharmaceuticals was incorporated on 26 November 2008, making it 18+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Senses Pharmaceuticals by revenue are Indi Pharma Private Limited, CGG Infra India Private Limited, Kemppi India Private Limited, RRB Chemicals Private Limited, GNH India Pharmaceuticals Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Kapil Jhaver ceased to be Nominee Director on 07 Jun 2023. Rangarajan Vijayaragavan ceased to be Additional Director on 28 Sep 2022. Rangarajan Vijayaragavan was appointed as Director on 10 Jun 2022. Senses Pharmaceuticals has 15 board changes on record in total.
Senses Pharmaceuticals has 10 MSME Form 1 returns on record between 2019 and 2024, listing 252 overdue payments to 50 micro and small suppliers. The latest return was filed on 01 May 2024.